Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 4Completed 4Unknown 3Terminated 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 36Leukemia, Myeloid, Acute 27Colorectal Neoplasms 27Neoplasms 26Neoplasm Metastasis 22Recurrence 21Multiple Myeloma 20Advanced Solid Tumors 20Lymphoma, B-Cell 19Breast Neoplasms 18Pancreatic Neoplasms 14Lung Neoplasms 13Glioblastoma 13Carcinoma, Hepatocellular 13Lymphoma 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Hematologic Neoplasms 11Glioma 11Squamous Cell Carcinoma of Head and Neck 10Ovarian Neoplasms 10Melanoma 10Leukemia 10Advanced Solid Tumor 10Triple Negative Breast Neoplasms 9Prostatic Neoplasms 9Head and Neck Neoplasms 9Lymphoma, Non-Hodgkin 8Esophageal Neoplasms 8Myelodysplastic Syndromes 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Not yet recruiting × Locally Advanced or Metastatic Solid Tumors × Clear all
NCT07607054 2026-05-26

A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.

Shanghai EpimAb Biotherapeutics Co., Ltd.

Phase 1 Not yet recruiting
50 enrolled
Other solid neoplasm

Locally Advanced or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡